UBS Group’s Hi-Crush Inc. Common Stock HCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-20,000
Closed -$35K 8636
2019
Q3
$35K Sell
20,000
-100,000
-83% -$192K ﹤0.01% 6408
2019
Q2
$295K Buy
+120,000
New +$375K ﹤0.01% 4664
2017
Q3
Sell
-100,000
Closed -$1.08M 8142
2017
Q2
$1.08M Buy
+100,000
New +$1.37M ﹤0.01% 3547
2015
Q3
Sell
-36,800
Closed -$1.13M 8779
2015
Q2
$1.13M Buy
36,800
+36,500
+12,167% +$1.2M ﹤0.01% 3464
2015
Q1
$11K Sell
300
-700
-70% -$24.5K ﹤0.01% 7592
2014
Q4
$31K Buy
+1,000
New +$41.6K ﹤0.01% 7087

Other funds holding HCR

UBS Group's HCR Position: Q3 2020 in Review

UBS Group sold out of Hi-Crush Inc. Common Stock (HCR) in Q3 2020, closing a stake of 16,678 shares — an estimated $3K sold.

UBS Group first reported a position in HCR in Q4 2014 and held it in 23 quarters. The position peaked at $33.3M in Q4 2016. 13 funds tracked by Wall St. Rank hold HCR as of Q3 2020.

  • UBS Group reported no remaining Hi-Crush Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • UBS Group sold 16,678 Hi-Crush Inc. Common Stock shares in Q3 2020, an estimated $3K.
  • UBS Group first reported a position in Hi-Crush Inc. Common Stock in Q4 2014 and held it in 23 quarters.
  • UBS Group's Hi-Crush Inc. Common Stock position peaked at $33.3M in Q4 2016.
  • 13 funds tracked by Wall St. Rank held Hi-Crush Inc. Common Stock as of Q3 2020.

Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.